Benign neoplasm: Penis

CD2_BENIGN_PENIS

penile neoplasm: Cancers or tumors of the PENIS or of its component tissues.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only males	226837
2. Check conditions None	226837
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D29.0& Hospital discharge: ICD-9 — 2221 Hospital discharge: ICD-8 — 2221 Cause of death: ICD-10 — D29.0& Cause of death: ICD-9 — 2221 Cause of death: ICD-8 — 2221 2 out of 7 registries used, show all original rules.	68
4. Check minimum number of events None	68
5. Include endpoints None	68
6. Filter based on genotype QC (FinnGen only)	68

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D29
Name in latin: Neoplasma benignum penis

NAME	CD2_BENIGN_PENIS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	1
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D290
HD_ICD_9	2221
HD_ICD_8	2221
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D290
COD_ICD_9	2221
COD_ICD_8	2221
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Penis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Penis

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	661	-	661
Only index persons	598	-	598
Unadjusted period prevalence (%)
Whole population	0.02	-	0.02
Only index persons	0.02	-	0.02
Median age at first event (years)
Whole population	-	-	37.45
Only index persons	-	-	35.65

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	68	-	68
Unadjusted period prevalence (%)	0.03	-	0.03
Median age at first event (years)	44.10	-	44.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
65: Matched controls
650

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D29.0

ICD-10 Finland

Benign neoplasm: Penis

+∞

59.9

22210

ICD-8 Finland

Benign neoplasm of male genital organs, Penis

+∞

15.2

KGB00

NOMESCO Finland

Biopsy of penis

+∞

14.0

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

18.6

11.3

KGH10

NOMESCO Finland

Operation for phimosis

14.4

8.0

WX240

NOMESCO Finland

Penis blockade

77.1

6.6

C60.9

ICD-10 Finland

Malignant neoplasm: Penis, unspecified

+∞

6.3

C60.1

ICD-10 Finland

Malignant neoplasm: Glans penis

+∞

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.89

2.42

2.1

0.2

g/l

0.11

(1761482) Bacteria [#/volume] in Urine by Culture

3.98

2.21

3.0

4.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

248

1.96

1.95

8.6

8.7

1.2

mmol/l

0.21

212

(3049717) Cytology report of Urine Cyto stain

3.42

1.94

3.4

3.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

137

2.03

1.87

4.0

3.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

4.40

1.85

1.4

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.88

1.79

1.8

3.9

26.5

24.6

mmol/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

191

1.90

1.75

2.0

1.9

108.8

92.1

pmol/l

0.73

105

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

198

1.81

1.53

4.0

3.2

—

(3000330) Specific gravity of Urine by Test strip

2.67

1.49

4.0

—

(3002256) Pathology report gross observation

2.21

1.49

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3.29

1.46

3.0

1.9

—

(3002032) Base excess in Venous blood by calculation

2.24

1.42

2.1

3.7

2.3

1.6

mmol/l

0.26

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2.31

1.40

3.7

2.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3.09

1.38

3.0

2.7

—

(3012544) pH of Venous blood

2.19

1.36

2.1

4.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2.10

1.32

1.3

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.45

1.32

1.8

3.1

143.9

127.5

g/l

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.94

1.24

7.9

7.0

1.0

mmol/l

0.06

(3035350) Ketones [Presence] in Urine by Test strip

256

1.66

1.20

4.2

3.3

0.0

estimate

—

(3037467) Urinalysis macro (dipstick) panel - Urine

345

1.67

1.18

7.2

3.6

—

(42870588) Differential panel, method unspecified - Blood

184

1.67

1.16

7.9

6.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.96

1.13

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.18

1.06

1.9

6.9

24.2

24.6

mmol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2.01

1.05

4.2

2.2

—

(3003694) ABO and Rh group [Type] in Blood

135

1.68

1.05

1.2

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.79

1.00

1.4

2.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

202

1.56

0.93

4.4

3.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

259

1.53

0.92

5.8

4.4

0.0

estimate

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.09

0.89

2.0

3.6

67.1

60.1

—

(3037522) Nuclear Ab [Titer] in Serum

1.88

0.89

1.1

1.4

—

341.5

titre

—

(3026008) Bacteria identified in Urine by Culture

106

1.67

0.89

4.4

2.7

—

(3009261) Glucose [Presence] in Urine by Test strip

261

1.51

0.88

4.3

3.3

0.0

estimate

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.84

0.86

2.0

1.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.96

0.84

1.3

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

456

1.60

0.83

23.5

18.7

13.9

13.7

0.36

446

(40760892) CBC W Ordered Manual Differential panel - Blood

117

1.60

0.82

3.9

5.2

—

(4034850)

0.00

0.80

0.0

9.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.77

0.78

2.9

3.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

163

1.52

0.78

5.0

4.5

11.2

13.1

mg/mmol

0.08

116

(3032080) INR in Blood by Coagulation assay

228

1.47

0.77

4.4

8.2

1.1

1.3

inr

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.88

0.75

2.3

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.92

0.70

12.4

30.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

321

1.42

0.67

2.7

2.9

—

(3021589) Normoblasts [#/volume] in Blood

243

1.42

0.67

11.2

10.9

0.0

e9/l

0.50

194

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.61

0.0

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

0.00

0.61

0.0

2.7

—

395.8

—

(3000991) Gas panel - Venous blood

1.58

0.61

8.5

9.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

490

1.50

0.61

21.3

16.4

41.4

0.01

371

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.84

0.60

2.7

2.2

1.7

1.6

—

(3012516) Albumin [Mass/volume] in Urine

153

1.44

0.59

3.8

3.7

90.1

447.0

mg/l

0.49

115

(40768800) Prostate Pathology biopsy report

0.00

0.59

0.0

1.2

—

(3042936) Bacteria identified in Isolate by Culture

1.54

0.56

1.2

2.5

—

(4035726)

1.63

0.56

1.5

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

230

1.37

0.55

3.3

4.5

—

(40761511) CBC panel - Blood by Automated count

565

1.53

0.51

20.0

14.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.43

0.43

9.6

8.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.42

0.0

2.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.41

0.0

1.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

0.00

0.41

0.0

1.6

—

296.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.41

0.0

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.40

0.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.40

0.0

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

156

0.72

0.40

2.2

2.7

412.3

9638.6

umol/l

1.05

132

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.46

0.40

1.4

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

222

1.28

0.37

2.5

2.9

0.4

0.7

ug/l

3.44

150

(3044640) Blood type and Crossmatch panel - Blood

166

1.29

0.35

2.0

2.6

—

(3013512) EKG study

149

1.28

0.32

6.8

4.3

—

(36304419) Bacteria [Presence] in Urine

149

1.28

0.32

3.8

3.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

306

1.22

0.29

4.9

4.5

16.1

21.2

2.44

145

(40758558) Short blood count panel - Blood

132

1.28

0.29

10.4

7.2

—

(40768797) Stomach Pathology biopsy report

1.24

0.28

1.8

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.32

0.26

2.1

2.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

513

1.26

0.25

19.2

14.2

84.6

83.5

ml/min/173m2

0.13

424

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.38

0.24

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.24

0.22

1.4

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.21

0.0

1.6

—

62.3

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.21

0.0

4.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(40768804) Tissue Pathology biopsy report

185

1.20

0.21

2.4

2.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.21

0.0

1.1

—

(3019225) pH of Specimen

1.27

0.21

8.5

4.9

—

(4094501)

0.00

0.21

0.0

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

150.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.20

0.0

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.20

0.0

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

120

1.21

0.18

2.5

2.7

—

(3022145) Colonoscopy Study observation

1.14

0.18

1.1

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.16

0.17

4.1

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.22

0.15

3.6

2.3

11.8

13.9

umol/l

—

(3009343) pH of Capillary blood

1.18

0.10

5.2

3.0

—

7.4

—

(40761536) Microorganisms panel - Urine sediment

1.18

0.10

2.6

4.5

—

(3029937) Albumin [Presence] in Urine by Test strip

146

1.13

0.09

5.2

3.5

0.0

estimate

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.10

0.09

1.7

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

123

0.87

0.09

4.3

3.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

558

1.13

0.07

23.7

17.3

139.7

139.5

mmol/l

0.24

548

(3044889) 12 lead EKG panel

377

1.08

0.06

3.8

4.0

—

(1761868) Lipid panel - Serum or Plasma

209

1.08

0.05

3.7

2.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

550

0.91

0.05

21.0

14.4

23.8

26.4

mg/l

0.19

431

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

231

1.06

0.03

5.8

3.8

86.5

64.7

ng/l

0.16

159

(3023103) Potassium [Moles/volume] in Serum or Plasma

562

1.09

0.03

23.9

17.4

4.1

4.0

mmol/l

0.25

552

(3023368) Bacteria identified in Blood by Culture

153

1.06

0.01

5.5

5.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

5.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.9

—

(40768806) Pleura Pathology biopsy report

0.00

0.0

1.9

—

(3012441) Differential panel - Pleural fluid

0.00

0.0

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

4.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(4268621)

0.00

0.0

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.4

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

2.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

2.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

0.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.00

0.0

1.2

—

8.8

—

(3048689) Calprotectin [Mass/mass] in Stool

0.92

0.00

5.2

2.4

261.8

113.7

ug/g

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

0.90

0.00

1.5

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

2.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

12.9

—

650.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.2

—

(4306422)

0.00

0.0

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

0.95

0.00

1.5

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

2.5

—

(3000492) Spirometry study

0.98

0.00

1.7

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

2.9

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3051651) Icteric interference index of Serum or Plasma

0.00

-0.00

0.0

4.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

3.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

-0.00

0.0

1.6

—

(3044941) Cell count panel - Synovial fluid

0.00

-0.00

0.0

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

2.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3021788) Differential panel - Synovial fluid

0.00

-0.00

0.0

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

2.8

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

3.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_PENIS and mortality.

Females

No data

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_PENIS	1.07 [0.79, 1.44]	0.656
Birth year	0.988 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 74 out of 444 males with CD2_BENIGN_PENIS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_PENIS.

N-year risk	Females	Males
1	No data	0.182%
5	No data	1.191%
10	No data	3.334%
15	No data	6.002%
20	No data	10.271%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_PENIS – Benign neoplasm: Penis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Penis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints